Former Quest Executive Director Brings Extensive Strategic Marketing
OMAHA, Neb., Feb. 5 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO), today announced that it has appointed David P. Pauluzzi to its Board of Directors. Mr. Pauluzzi is currently a consultant at Water Street Healthcare Partners, a Chicago-based private equity firm specializing in the healthcare sector.
Prior to his current position, Mr. Pauluzzi served as Executive Director/VP of Quest Diagnostics, the nation's leading provider of diagnostic testing, information and services, where he directed operations, marketing and sales for its Esoteric Anatomic Pathology Business and built a direct sales and marketing organization for its Hospital Division. He also served as V.P. of Sales and Marketing and Chief Operating Officer for US LABS, a national anatomic pathology reference laboratory, where he hired and developed the Company's sales and marketing organization and launched national marketing and re-branding initiatives. Mr. Pauluzzi has also served as Senior Director of World Wide Marketing for Ventana Medical Systems, a global leader in tissue- based cancer diagnostics, and as District Sales Manager and International Marketing Manager for the Diagnostics Division of global healthcare company Abbott Laboratories.
Craig Tuttle, Transgenomic President and Chief Executive Officer,
stated, "Mr. Pauluzzi brings more than 20 years of worldwide diagnostic and
clinical laboratory experience with both leading and emerging healthcare
service companies that includes extensive expertise in strategic marketing,
developing and managing sales organizations, and senior level diagnostic
product and systems sales. His cancer diagnostic and services industry
experience includes anatomic pathology, genomics, proteomics and the
pharmacogenomics market serving physicians, labs and hospitals. We are
excited to have him join the C
|SOURCE Transgenomic Inc.|
Copyright©2008 PR Newswire.
All rights reserved